Synthetic Biology for Bio-based Isoprene

Introduction

Isoprene is a five-carbon (C5) unsaturated hydrocarbon used predominantly in the production of synthetic rubber, especially polyisoprene, which mimics the properties of natural rubber. Conventional isoprene is derived from crude oil or naphtha cracking, making it volatile in cost and carbon-heavy in origin.

Synthetic biology offers a breakthrough by enabling microbial production of bio-isoprene from renewable feedstocks such as sugars, lignocellulose hydrolysates, or even CO₂. This involves reprogramming microbial hosts—like E. coli, Bacillus, or cyanobacteria—with engineered isoprenoid biosynthesis pathways to convert biomass into isoprene monomers, offering a sustainable, scalable, and climate-friendly route to rubber production.

What Products Are Produced?

Bio-isoprene (C₅H₈)

• For polyisoprene-based synthetic rubber
• Raw material for elastomers, adhesives, sealants
• Intermediate in fine chemicals and flavor compounds

Pathways and Production Methods

1. MEP Pathway (Native in Bacteria)

• Glucose → Pyruvate + G3P → IPP → DMAPP → Isoprene
• Uses isoprene synthase (IspS) to convert DMAPP to isoprene
• Hosts: E. coli, Bacillus subtilis, cyanobacteria

2. MVA Pathway (Heterologous)

• Introduced into E. coli or S. cerevisiae
• Acetyl-CoA → HMG-CoA → Mevalonate → IPP/DMAPP → Isoprene
• More flexible and tunable than MEP pathway
• Used by major players due to higher flux capacity

3. Photosynthetic CO₂-to-Isoprene

• Cyanobacteria genetically modified with MEP + IspS
• Direct conversion of sunlight and CO₂ into isoprene
• Zero-carbon route but still in early development

Catalysts and Key Tools Used

Key Enzymes:

• DXS, DXR (in MEP pathway)
• HMGR, MVK (in MVA pathway)
• Isoprene synthase (IspS) – terminal enzyme releasing volatile isoprene

Synthetic Biology Tools:

• CRISPR/Cas9 and Multiplex Automated Genome Engineering (MAGE)
• Dynamic regulation to avoid accumulation of toxic intermediates
• Codon optimization and protein scaffolding for pathway tuning
• Gas stripping bioreactors for in situ isoprene recovery

Host Strain Engineering:

• Stress tolerance for volatile isoprene
• Enhanced precursor supply (Acetyl-CoA, NADPH)

Case Study: Genencor (DuPont) + Goodyear – Industrial-Scale Bio-Isoprene

Highlights

• Engineered E. coli strain with mevalonate pathway + IspS
• Produced bio-isoprene from glucose at 60 g/L in pilot reactors
• Integrated with Goodyear’s rubber polymerization platform
• Used gas-phase recovery to reduce fermentation toxicity

Timeline

• 2008 – Genencor and Goodyear announce collaboration
• 2011 – Pilot production of bio-isoprene achieved
• 2015 – Rubber tire prototypes made with 100% bio-isoprene
• 2023 – Pathway licensed for commercialization in Asia

Global and Indian Startups Working in This Area

Global

• Genencor/DuPont – Pioneer in bio-isoprene production
• Amyris (USA) – Mevalonate pathway platform for terpenes
• LanzaTech – CO₂ to isoprenoid R&D using gas fermentation
• Arzeda – Designing enzymes for IPP and DMAPP balance

India

• IIT Delhi & CSIR-IMTECH – MVA pathway engineering in E. coli
• IIT Guwahati – Synthetic pathway modeling for isoprene synthesis
• Godavari Biorefineries – Exploring isoprene as a sugar platform product
• Synthezyme Biotech – Early-stage work on enzyme design for terpene monomers

Market and Demand

The global isoprene market is valued at USD 5.5 billion (2023) and is expected to reach USD 8.2 billion by 2030, growing at a CAGR of ~6%, driven by demand in rubber tires, automotive elastomers, and adhesives. Bio-isoprene is projected to claim ~8–10% market share by 2030.

Major End-Use Segments:

• Tires and automotive components (polyisoprene rubber)
• Footwear, seals, gaskets
• Pressure-sensitive adhesives and sealants
• Medical latex and surgical gloves

Key Growth Drivers

• Volatility and emissions from petro-isoprene production
• Global OEMs shifting to sustainable tire materials
• Synthetic biology enabling high-yield, tunable pathways
• CO₂-to-isoprene platforms offer negative-emission products
• Growing demand for bio-content certification (e.g., USDA, EU)

Challenges to Address

• Volatility and toxicity of isoprene hinders microbial growth
• Need for in situ gas-phase stripping and recovery
• Complex IPP/DMAPP flux balancing to avoid bottlenecks
• High capital costs for scaled bioreactors with VOC handling
• In India: need for downstream polymerization partners

Progress Indicators

• 2009–2011 – Isoprene synthase introduced into E. coli, pathway scaled
• 2013–2015 – Rubber-grade bio-isoprene synthesized and tested in tires
• 2018 – Cyanobacteria engineered for photosynthetic isoprene
• 2022 – Indian teams begin de novo IPP pathway construction
• 2024 – Hybrid glucose + CO₂ bioreactors under evaluation for isoprene

Bio-isoprene via glucose fermentation is at TRL 7–8 globally, with pilot-scale integration into tire and elastomer supply chains. In India, it remains at TRL 4–5, with academic and early-stage industrial interest in process development.

Conclusion

Synthetic biology-driven isoprene production is a powerful step toward green rubber and elastomer manufacturing. By harnessing engineered microbes to convert renewable sugars or CO₂ into isoprene, this innovation offers a cleaner, scalable alternative to fossil-derived monomers.

As global tire and automotive brands adopt renewable content, and with India’s emerging strength in fermentation and biomanufacturing, bio-isoprene could play a pivotal role in shaping a sustainable polymer economy.

Wish to have bio-innovations industry or market research support from specialists for climate & environment? Talk to BioBiz team – Call Muthu at +91-9952910083 or send a note to ask@biobiz.in